14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ADMS
Delisted

Adamas Pharmaceuticals Stock Predictions

$8.22
+0 (+0%)
At Close: May 27, 2022
Currently predicting for Wed, 24 Apr 2024

ADMS Predictions History

3 years ago
JS predicted that ADMS for 2021-02-25 is going $4.83 (1.68%)

3 years ago
Kevin Ripper predicted that ADMS for 2021-02-25 is going $5.00 (5.26%)

Rank:

3 years ago
Rory predicted that ADMS for 2021-02-02 is going

Rank:

3 years ago
JS predicted that ADMS for 2020-12-07 is going $4.93 (1.02%)

3 years ago
JS predicted that ADMS for 2020-12-04 is going $4.73 (-3.27%)

3 years ago
JS predicted that ADMS for 2020-06-01 is going $2.71 (0.74%)

3 years ago
Joseph Hervieux predicted that ADMS for 2020-06-01 is going

Rank:

4 years ago
Alan predicted that ADMS for 2019-08-02 is going $5.91 (-3.11%)

4 years ago
NameNotImportant predicted that ADMS for 2019-05-03 is going $6.92 (8.29%)

4 years ago
NameNotImportant predicted that ADMS for 2019-05-01 is going $6.22 (-1.89%)

Click to get the best stock tips daily for free!

About Adamas Pharmaceuticals

Adamas Pharmaceuticals Adamas Pharmaceuticals, Inc., a pharmaceutical company, focuses on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems. The company’s lead product candidate is the ADS-5102 that is in Phase 3 clinical development for the treatment of levodopa-induced dyskinesia, a movement disorder associated with Parkinson’s disease; and in a Phase 2 clinical study for the treatment of symptoms assoc... ADMS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT